Vonjo was also shown to improve overall survival in patients with myelofibrosis treated with Vonjo in the real-world setting. Improvements in thrombocytopenia and anemia were observed in patients with ...

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

A recently published report describes the diagnosis and treatment of a case of iron-deficiency anemia–associated thrombocytopenia secondary to recurrent nosebleeds. While thrombocytosis is known to be ...

Real-world data on momelotinib shows improved hemoglobin levels and transfusion independence in MF patients with anemia, surpassing previous clinical trial results. By six months, 45.7% of patients ...

"Patients with cancer-associated thrombosis are both at risk of recurrent venous thromboembolism and bleeding during extended anticoagulant," said Mahé in a recorded talk of her ASH poster ...

Promacta (eltrombopag) is a prescription drug used to treat certain blood disorders, including low platelet level. The drug comes as an oral tablet and an oral liquid suspension. It’s usually taken ...

Omidubicel is a nicotinamide modified unrelated allogeneic hematopoietic progenitor cell therapy derived from cord blood.

Cirrhosis is a risk factor for anemia, and anemia can indicate worse cirrhosis outcomes. Cirrhosis may cause anemia, leading to red blood cell destruction, folate deficiency, or internal bleeding.

Jakafi (ruxolitinib) can cause side effects that range from mild to serious. More common side effects include dizziness, headache, and anemia. If side effects from Jakafi become difficult to tolerate, ...

In patients with cancer, systemic microvascular metastases and bone marrow involvement can cause microangiopathic hemolytic anemia and thrombocytopenia. This occurs most often in patients with known ...